Currently out of the existing stock ratings of Jonathan Wolleben, 183 are a BUY (100%).

Jonathan Wolleben

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Wolleben, currently employed at JMP, carries an average stock price target met ratio of 23.59% that have a potential upside of 40.18% achieved within 143 days.

Jonathan Wolleben’s has documented 359 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DBVT, DBV Technologies at 27-May-2025.

Wall Street Analyst Jonathan Wolleben

Analyst best performing recommendations are on DBVT (DBV TECHNOLOGIES).
The best stock recommendation documented was for DBVT (DBV TECHNOLOGIES) at 3/4/2025. The price target of $10 was fulfilled within 69 days with a profit of $5.7 (132.56%) receiving and performance score of 19.21.

Average potential price target upside

ALT Altimmune CLSD Clearside Biomedical CRNX Crinetics Pharmaceuticals DBVT DBV Technologies LRMR Larimar Therapeutics OCUL Ocular Therapeutix PRQR ProQR Therapeutics BV BCRX BioCryst Pharmaceuticals RLYB Rallybio Corp PHVS Pharvaris BV MDGL Madrigal Pharmaceuticals AURA Aura Biosciences PTGX Protagonist Therapeutics ALLK Allakos MIRM Mirum Pharmaceuticals SPRB Spruce Biosciences  RYTM Rhythm Pharmaceuticals SVRA Savara

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$6.57 (120.99%)

$12

1 months 29 days ago
(03-Apr-2025)

0/17 (0%)

$7.54 (169.06%)

Buy

$25

$19.57 (360.41%)

$25

1 months 30 days ago
(02-Apr-2025)

0/15 (0%)

$20.22 (423.01%)

Buy

$20

$14.57 (268.32%)

$20

9 months 20 days ago
(12-Aug-2024)

4/16 (25%)

$13.78 (221.54%)

214

Buy

$25

$19.57 (360.41%)

$25

11 months 11 days ago
(21-Jun-2024)

3/14 (21.43%)

$18.59 (290.02%)

42

Hold

$26

1 years 1 months 3 days ago
(29-Apr-2024)

0/6 (0%)

$12.36 (90.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jonathan Wolleben is most bullish on?

Potential upside of $167.74 has been obtained for MDGL (MADRIGAL PHARMACEUTICALS)

Which stock is Jonathan Wolleben is most reserved on?

Potential downside of $6.34 has been obtained for PRQR (PROQR THERAPEUTICS BV)

What Year was the first public recommendation made by Jonathan Wolleben?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?